Expression of Met and/or its ligand HGF increases during progression of HNSCC and there is a substantial increase of Met levels in affected lymph nodes, compared to corresponding primary tumors [82,83,84,87,88]. This evidence concerns the gene HGF and head and neck squamous cell carcinoma.